Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Fianchi, Luana  [Clear All Filters]
2024
Renga G, Nunzi E, Stincardini C, Pariano M, Puccetti M, Pieraccini G, Di Serio C, Fraziano M, Poerio N, Oikonomou V, et al. CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis. Blood. 2024.
Aiello TFrancesco, Salmanton-García J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, Farina F, Dávila-Valls J, Martín-Pérez S, El-Ashwah S, et al. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica. 2024.
2022
Marasco V, Piciocchi A, Candoni A, Pagano L, Guidetti A, Musto P, Bruna R, Bocchia M, Visentin A, Turrini M, et al. Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study. Br J Haematol. 2022.
2019
Falconi G, Fabiani E, Criscuolo M, Fianchi L, Finelli C, Cerqui E, Pelosi E, Screnci M, Gurnari C, Zangrilli I, et al. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome. Leuk Res. 2019;84:106191.
2018
Falconi G, Fabiani E, Piciocchi A, Criscuolo M, Fianchi L, Rossi ELLindfors, Finelli C, Cerqui E, Ottone T, Molteni A, et al. Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes. Leukemia. 2018.
2015
Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CSpertilli, Bellesi S, Hohaus S, Voso MTeresa, D'Alò F, Leone G. Impairment of PI3K-AKT and WNT-β catenin pathways in bone marrow mesenchymal stem cells isolated from patients with Myelodysplastic Syndromes. Exp Hematol. 2015.